Last updated 2026-06-18
- Raised $2M funding round, Aug 2015
- Raised grant, Jun 2017
Total raised
$2.0M
Last: Grant 2017-06
Stage
Seed
Founded
2012
Headcount
4
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences
About
NewPace develops a flexible and subcutaneous implantable cardioverter defibrillator (ICD) with no leads within the heart with a wireless rechargeable battery and Bluetooth communication.
The NewPace defibrillator differs from standard ICDs in that it does not have leads in the heart. The rechargeable device is implanted subcutaneously with no need for fluoroscopy and communicates via Bluetooth with a smartphone. The string-shaped defibrillator requires one hour per year for wireless recharge and communicates at low energy with smartphones for monitoring. The subcutaneous implantation requires no in-patient care.
NewPace partners with China-based Haisco Pharmaceutical.
Funding history · 2 rounds · $2.0M total
2017-06
Grant
Undisclosed
2015-08
Q&A
- What is Newpace's primary product?
- Newpace develops a flexible and subcutaneous implantable cardioverter defibrillator (ICD) that does not require leads within the heart. It features a wireless rechargeable battery and Bluetooth communication.
- How does Newpace's defibrillator differ from standard ICDs?
- The Newpace defibrillator is implanted subcutaneously without leads in the heart, eliminating the need for fluoroscopy. It is rechargeable, requires one hour per year for wireless recharging, and communicates via Bluetooth with a smartphone for monitoring.
- When was Newpace founded?
- Newpace was founded in October 2012.
- What is the total amount of funding Newpace has raised?
- Newpace has raised a total of $2,000,000.
- Which investors participated in Newpace's August 2015 funding round?
- In August 2015, Newpace received funding from Net Capital Ventures and BioStar Capital.
- Has Newpace received any grants?
- Yes, Newpace received a grant from EU Horizon 2020 in June 2017.
- Who is a co-founder and executive at Newpace?
- Avi Broder is a Co-founder, CFO & VP BD at Newpace.
- What is Newpace's primary sector?
- Newpace's primary sector is Health Tech & Life Sciences.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesLife Support
Technologies
CommunicationsBluetoothMaterials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2BB2B2C
Highlights
1 Patents
Tags
medical-devicesheart-failuredoctorshospitalsmonitoringbluetoothcardiologywireless-communicationpatientschronic-patients
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | newpacemedical.com |
|---|---|
| linkedin.com/company/28123492 |
Identifiers & details
| Founded | 2012-10 |
|---|---|
| Employees (exact) | 4 |
Radar intelligence
Patents
| EPO | 17 |
|---|
Web history (Wayback)
| Domain | newpacemedical.com |
|---|
Certificate / subdomain footprint
| Subdomains | 6 |
|---|